According to immunohistochemical markers such as the estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) status, and Ki-67 expression, four distinct molecular subtypes of BC have been established, each characterized by unique gene expression profiles. This evidence concerns the gene ESR1 and breast cancer.